War in Ukraine Disrupts Trials, Cancer Care
Elie Dolgin • May 2, 2022
The war in Ukraine is disrupting routine patient care, clinical trials, and basic cancer research—with potentially dire consequences. Physicians and researchers are helping patients as best they can, but cancer mortality is expected to rise in the country, and the impact on research could slow medical progress.
Continue reading at Cancer Discovery.
Circulating biomarkers are quickly becoming a crucial part of diagnosis and disease monitoring for physicians, researchers — and even some consumers.
Zebras and giraffes offer one another protection without food competition.